VANGUARD GROUP INC - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 41 filers reported holding NRX PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.99 and the average weighting 0.0%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$377,154
-47.2%
1,450,593
-1.9%
0.00%
Q2 2023$714,687
-26.6%
1,478,1530.0%0.00%
Q1 2023$974,250
-39.2%
1,478,153
+2.4%
0.00%
Q4 2022$1,601,911
+50.4%
1,443,163
+0.2%
0.00%
Q3 2022$1,065,000
+62.1%
1,440,265
+31.6%
0.00%
Q2 2022$657,000
-75.1%
1,094,713
+1.8%
0.00%
Q1 2022$2,634,000
-53.0%
1,075,317
-8.3%
0.00%
Q4 2021$5,603,000
-39.6%
1,172,233
+17.2%
0.00%
Q3 2021$9,271,000
+25.2%
1,000,123
+56.9%
0.00%
Q2 2021$7,407,000637,4160.00%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 325,000$84,5000.06%
Texas Capital Bank Wealth Management Services Inc 63,290$16,4550.00%
XTX Topco Ltd 11,809$3,0700.00%
United Asset Strategies, Inc. 18,300$4,7580.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 160,700$41,7820.00%
UBS Group AG 1,210$3150.00%
NewEdge Advisors, LLC 7,125$1,8530.00%
Lido Advisors, LLC 13,000$3,3800.00%
OSAIC HOLDINGS, INC. 11,125$2,8910.00%
WELLS FARGO & COMPANY/MN 5,379$1,3990.00%
View complete list of NRX PHARMACEUTICALS INC shareholders